We are excited to announce that BrightInsight has been named to Forbes prestigious ranking of America’s Best Startup Employers for 2024 for the second year in a row! 🏆 brightinsight.com/blog/brigh…

In this interview, @JamieJay2 spoke with @Butlerjustin, Partner at @EclipseVentures, about the firm’s investment thesis when it comes to GenAI, the potential of GenAI & digital to improve patient-provider communication, and how AI- powered technologies will enable data sharing.

Adoption and scaling of #digitalhealth remains a significant challenge for life science companies. Explore how you can make your digital solutions stand out in our new white paper, Go-to-Market Strategies for Patient-Facing Digital Health Solutions: bit.ly/3SZukwQ

This recognition was fueled by BrightInsight’s multiple global app launches, product and platform enhancements and new partnerships in 2023, all of which contributed to our 431% revenue growth. bit.ly/3sMrAs9

We are proud to share that BrightInsight was awarded 307th place in the Deloitte Technology #Fast500, a ranking of the 500 fastest-growing technology, media, telecommunications, life sciences, fintech, and energy tech companies in North America! 🏆

But #pharma would do well to trade its FOMU for FOMO—fear of missing out—because #digitalhealth technologies can unlock huge amounts of value while addressing critical adoption and adherence issues. @_KalPatel @Forbes bit.ly/44RJXsO

When it comes to #digitalhealth, the pharmaceutical industry seems to be stricken with FOMU—fear of messing up. It’s not without reason. After all, patients’ lives are on the line, and pharma executives face a host of other high-pressure risks. @_KalPatel @Forbes

What an exciting Q2 for #BrightInsight! 🤩🚀 Some highlights includes earning the @Frost_Sullivan IoT Healthcare Solutions 2023 Global Company of the Year Award, receiving the CE mark and more. Here’s a video recap of our Q2 highlights! 🌟 youtu.be/_ZtYZtcHGP8

Our own @_KalPatel is joined by Brad Gescheider from @sanofi Wainwright Fishburn from @CooleyLLP and @jameslu20 from @my_helix to discuss partnering strategies for success in digital health 🤩 #BIO2022

.@paularthurupham of @roche/@genentech talks about measuring ROI of #SaMD by thinking about the “Return to Patient” and the benefits you’re delivering to patients. #DTxWest

Dave Matthews (@e2pi) kicks off our #DTxWest panel and shares recent stat: “100% of #digitalhealth leaders agree that #SaMD initiatives take longer and cost more than originally believed.”

Attending #DTxWest? Be sure to catch the Discussion Panel: Minding the Gap: How to align expectations and realities when building Software as a Medical Device at 3:40PM PST today!

“In the early days of Pharma, we didn’t have device groups- it was an afterthought. Now that would be preposterous. Digital will be the same, becoming an integrated part of the drug lifecycle development from patient identification to dosing to adherence.” - @_KalPatel #DTxEast

Attending #DTxEast? Stop by our booth to meet with the #BrightInsight team! We also have a virtual booth for all those attending virtually.

Today BrightInsight announced our $101M Series C funding led by @gcvp! This funding will enable #BrightInsight to continue our hypergrowth, and to support the development and launch of game-changing #digitalhealth solutions for our customers. xitter.cf/home